Antimicrobial Resistance (AMR) is a growing global health crisis that claims thousands of lives annually. India, with its high infection burden and massive, often unregulated, antimicrobial consumption, is at the forefront of this challenge.

​

We believe that data-driven, multicentric surveillance is key to understanding, monitoring, and combating this threat. This research initiative seeks to map the prevalence of Multidrug-Resistant (MDR), Extensively Drug-Resistant (XDR), and Pandrug-Resistant (PDR) organisms across a diverse set of healthcare organizations, including teaching, non-teaching, private, and government healthcare institutions.